Has Brett Sheridan, MD received payments from drug or device companies?

Yes. Drug and device makers reported $72,412 in general payments to Brett Sheridan, MD across 188 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Brett Sheridan, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Brett Sheridan, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Brett Sheridan, MD

Thoracic Surgery (Cardiothoracic Vascular Surgery) · San Francisco, CANPI 1710072988

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $52,475 of the $72,412 with a category attached, or 72.5%. Abbott accounts for 85.0% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2019 at $26,773 and has fallen 59.3% since, to $10,893 in 2025. Among thoracic surgery (cardiothoracic vascular surgery) clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$72,412in general payments, 2019–2025

Across 188 payments — averaging $385.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Abbott$62K
Edwards Lifesciences$8K
Medtronic$1K
Abiomed$641
Atricure, Inc.$481
Johnson & Johnson$212
plus $394 from 6 others

$183,408in research payments, 2019–2025

Across 59 payments — averaging $3108.60 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Abbott$183K

What the payments were for

Consulting fees$52,47572%
Speaking & faculty fees$6,7509%
Travel & lodging$3,5325%
Food & beverage$9,65513%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Abbott	97	$61,583
Edwards Lifesciences	49	$7,872
Medtronic(2 entities)	14	$1,229
Abiomed	8	$641
Atricure, Inc.	8	$481
Johnson & Johnson(2 entities)	5	$212
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)	1	$121
Livanova USA, Inc.	1	$120
Heartflow, Inc.	1	$55
Paragonix Technologies, Inc.	1	$44
Boehringer Ingelheim	2	$32
Cathworks, Inc.	1	$22

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

HeartMate 3 Left Ventricular Dev$24,466
THORATEC HEARTMATE 3 LVAS IMPLANT KIT$10,842
2ND GEN CENTRIMAG PRIMARY CONSOLE$10,200
Cardiovascular- Research only$6,750
Edwards SAPIEN 3 Transcatheter Heart Valve$5,505
CardioMEMS HF System$4,050
CentriMag$2,700
CoreValve Evolut$620
CARDIOMEMS$457
SAPIEN 3 Ultra RESILIA$431
PROLENE$298
Impella$251
PASCAL$185
HeartMate Touch$180
EVOQUE$178
HeartMate 3 Left Ventricular Assist Device$169
SYNERGY ABLATION SYSTEM$163
ATRICLIP LAA EXCLUSION SYSTEM$163
VISTASEAL$149
Edwards SAPIEN 3 Ultra Transcatheter Heart Valve$140

How this compares

$72,412 in reported general payments places this provider in the 90th percentile of 546 thoracic surgery (cardiothoracic vascular surgery) providers in California.

See all thoracic surgery (cardiothoracic vascular surgery) providers in California →

Medicare billing

Part B allowed, 2024

$374,089

Medicare patients

197

Services billed

1,037

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other thoracic surgery (cardiothoracic vascular surgery) in San Francisco

Gavitt WoodardSan Francisco$135K
Jason SmithSan Francisco$95K
Amy FiedlerSan Francisco$67K
Thomas FogartyPortola Valley$3.7M
Steven GundryPalm Springs$1.6M
Armin KiankhooySaint Helena$941K
Ara KlijianMurrieta$916K
Gregory FontanaThousand Oaks$875K
Gansevoort DunningtonSaint Helena$764K
Wilson TsaiWalnut Creek$680K

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →